
77.69 Delayed Data As of Jul 01 | ![]() Today’s Change | 61.91 Today|||52-Week Range 84.86 | +5.84% Year-to-Date |
3 Bargain Stocks Near 52-Week Lows to Buy and Forget Jun 29 / StockNews.com - Paid Partner Content | 3 Cheap Growth Stocks Near Their 52-Week Lows to Buy and Forget Jun 26 / MotleyFool.com - Paid Partner Content |
5 High-Performing Cathie Wood Stocks as of June Jun 28 / GuruFocus News - Paid Partner Content | Novartis' (NVS) Oncology Drugs Get Approval for Label Expansion Jun 23 / Zacks.com - Paid Partner Content |
Previous close | 75.97 |
Today’s open | 75.45 |
Day’s range | 75.43 - 77.86 |
Volume | 83,853 |
Average volume (3 months) | 1,432,055 |
Market cap | $17.2B |
Earnings growth (last year) | -- |
Earnings growth (this year) | -50.37% |
Earnings growth (next 5 years) | +25.46% |
Revenue growth (last year) | +11.98% |
P/E ratio | 18.5 |
Price/Sales | 5.46 |
Price/Book | 4.55 |
Today’s change | Today’s % change | |
---|---|---|
ALNYAlnylam Pharmaceutic... | +2.42 | +1.66% |
HZNPHorizon Therapeutics... | +1.07 | +1.34% |
CTLTCatalent Inc | -0.31 | -0.29% |
VTRSViatris Inc | +0.23 | +2.24% |
Next reporting date | August 2, 2022 |
EPS forecast (this quarter) | $0.54 |
Annual revenue (last year) | $3.0B |
Annual profit (last year) | $948.6M |
Net profit margin | 31.76% |
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Wilmington, Delaware |